A database of FDA approved therapeutic peptides and proteins
ID1475 | ThPPIDTh1095 | NameRanibizumab | Peptide SequenceLight Chain SASQDISN Full view | Length447 | Functional ClassificationIIa | DiseaseHematological/Eye Disorder | BrandLucentis | CompanyGenentech | Physical AppearanceSterile, colorless to pale yellow solution | Route of AdministartionIntravitreal injection | CategoryOphthalmics | TargetVascular endothelial growth factor A |
ID1529 | ThPPIDTh1108 | NamePegaptanib | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIa | DiseaseHematological/Eye Disorder | BrandMacugen | CompanyGilead Sciences | Physical AppearanceSterile, aqueous solution containing pegaptanib sodium for intravitreous injection | Route of AdministartionIntravitreal injection | CategoryIntended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. | TargetN.A. |
ID1615 | ThPPIDTh1133 | NameAflibercept | Peptide SequenceSDTGRPFVEMYSEIPEIIHM Full view | Length431 | Functional ClassificationIb | DiseaseCancer | BrandEylea | CompanyRegeneron Pharmaceuticals | Physical AppearanceSterile, clear, and colorless to pale yellow solution. | Route of AdministartionIntravitreal injection | CategoryAntineoplastic Agents and Ophthalmics | TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B |
ID1622 | ThPPIDTh1135 | NameOcriplasmin | Peptide SequenceTruncated heavy chai Full view | Length251 | Functional ClassificationIc | DiseaseEye Disorder | BrandJetrea | CompanyThromboGenics NV | Physical AppearanceSterile, clear and colorless solution with no preservatives | Route of AdministartionIntravitreal injection | CategoryOphthalmics | TargetFibronectin,Alpha-2-macroglobulin,Alpha-2-antiplasmin |